Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer

Withdrawn before enrolling · Not applicable

Conditions studied: Estrogen Receptor Positive, Obesity, Progesterone Receptor Positive, Stage I Uterine Corpus Cancer, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer

In brief

This pilot clinical trial studies exercise and diet intervention in promoting weight loss in obese patients with stage I endometrial cancer. Exercise and diet may cause weight loss and minimize the risk of gynecologic surgery related to being overweight in patients with endometrial cancer.

Key facts

Study ID

NCT03042897

Run by

University of Southern California

People needed

0

Starts

2017-09-08

Expected to finish

2019-07-31

Last updated by the study team

2020-12-17

Who can join

Age: 19 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Clinical stage I EC
• Low grade disease positive for estrogen and progesterone receptors
• Body mass index (BMI) >= 30 kg/m\^2
• No history of any musculoskeletal, cardiorespiratory or neurological diseases that preclude the participation in exercise
• Self ambulatory and without use of assistive walking devices
• Is not a candidate for immediate hysterectomy, following evaluation by a physician, due to desire to preserve fertility, due to degree of obesity, due to comorbidities, or due to patient refusal of hysterectomy
• Must agree to take progestin agents (i.e., oral agents or MIRENA intrauterine device [IUD] which are accepted treatments for low grade uterine malignancies to control their disease while the intervention is ongoing)
• Note: potential participants WILL NOT be asked to delay surgery to participate in this pilot study

You may not qualify if…

• Patients with metastatic disease
• BMI =< 29.9 kg/m\^2
• History of any musculoskeletal, cardiorespiratory or neurological diseases that preclude the participation in exercise
• Is not self ambulatory and relies on the use of assistive walking devices
• Is a candidate for immediate hysterectomy, following evaluation by a physician
• In judgement of a physician, is not a candidate for progestin agents

Where it is running

• USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.